Formyl peptide receptors and Annexin A1: complementary mechanisms to infliximab in murine experimental colitis and Crohn's disease (2021)
- Authors:
- USP affiliated authors: FARSKY, SANDRA HELENA POLISELLI - FCF ; VIEIRA, ANDREA - FM ; SILVA, MARINA DE PAULA - FCF ; ROCHA, GUSTAVO HENRIQUE OLIVEIRA DA - FCF ; BROERING, MILENA FRONZA - FCF ; SANDRI, SILVANA - FCF
- Unidades: FCF; FM
- DOI: 10.3389/fimmu.2021.714138
- Subjects: COLITE; DOENÇA DE CROHN; RECEPTORES; PEPTÍDEOS; BIOMARCADORES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Frontiers in Immunology
- ISSN: 1664-3224
- Volume/Número/Paginação/Ano: v. 12, p. 1-12 art. 714138, 2021
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
SILVA, Marina de Paula et al. Formyl peptide receptors and Annexin A1: complementary mechanisms to infliximab in murine experimental colitis and Crohn's disease. Frontiers in Immunology, v. 12, p. 1-12 art. 714138, 2021Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2021.714138. Acesso em: 31 mar. 2026. -
APA
Silva, M. de P., Rocha, G. H. O. da, Broering, M. F., Queiroz, M. L., Sandri, S., Loiola, R. A., et al. (2021). Formyl peptide receptors and Annexin A1: complementary mechanisms to infliximab in murine experimental colitis and Crohn's disease. Frontiers in Immunology, 12, 1-12 art. 714138. doi:10.3389/fimmu.2021.714138 -
NLM
Silva M de P, Rocha GHO da, Broering MF, Queiroz ML, Sandri S, Loiola RA, Oliani SM, Vieira A, Mauro Perretti, Farsky SHP. Formyl peptide receptors and Annexin A1: complementary mechanisms to infliximab in murine experimental colitis and Crohn's disease [Internet]. Frontiers in Immunology. 2021 ; 12 1-12 art. 714138.[citado 2026 mar. 31 ] Available from: https://doi.org/10.3389/fimmu.2021.714138 -
Vancouver
Silva M de P, Rocha GHO da, Broering MF, Queiroz ML, Sandri S, Loiola RA, Oliani SM, Vieira A, Mauro Perretti, Farsky SHP. Formyl peptide receptors and Annexin A1: complementary mechanisms to infliximab in murine experimental colitis and Crohn's disease [Internet]. Frontiers in Immunology. 2021 ; 12 1-12 art. 714138.[citado 2026 mar. 31 ] Available from: https://doi.org/10.3389/fimmu.2021.714138 - Red light-emitting diode treatment improves tissue recovery in DSS-induced colitis in mice
- Pioglitazone-mediated attenuation of experimental colitis relies on cleaving of annexin A1 released by macrophages
- Cellular and molecular mechanisms of environmental pollutants on hematopoiesis
- Imunotoxicologia
- Cisplatin treatment modulates Annexin A1 and inhibitor of differentiation to DNA 1 expression in cervical cancer cells
- Annexin A1/Formyl peptide receptor pathway controls uterine receptivity to the blastocyst
- Role of annexin A1 on pioglitazone mediated anti-inflammatory effects on experimental ulcerative colitis
- Pioglitazone attenuates the effects of peripheral inflammation in a human in vitro blood–brain barrier model
- Role of Annexin A1 Secreted by Neutrophils in Melanoma Metastasis
- Immunotoxic mechanisms of cigarette smoke and heat-not-burn tobacco vapor on Jurkat T cell functions
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
3046018.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
